Antilaminin-1 antibodies in cutaneous lupus erythematosus patients

Abstract

Get full access to this article

View all access options for this article.

References

1 Alahlafi AM Wordsworth P Wojnarowska F . The lupus band: do the autoantibodies target collagen VII. Br J Dermatol 2004; 150: 504–510.

2 Alahlafi AM Wordsworth P Lakasing L Davies D Wojnarowska F . The basement membrane zone in patients with systemic lupus erythematosus: immunofluorescence studies in the skin, kidney and amniochorion. Lupus 2004; 13: 594–600.

3 Ben-Yehuda A Rasooly L Bar-Tana R . The urine of SLE patients contains antibodies that bind to the laminin component of the extracellular matrix. J Autoimmun 1995; 8: 279–291.

4 Amital H Heilweil-Harel M Ulmansky R . Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption. Rheumatology 2007; 46: 1433–1437.

5 Amital H Heilweil M Ulmansky R . Treatment with a laminin-derived peptide suppresses lupus nephritis. J Immunol 2005; 175: 5516–5523.

6 Rescan PY Clement B Yamada Y . Expression of laminin and its receptor LBP-32 in human and rat hepatoma cells. Hepatology 1991; 13: 289–296.

7 Mannik M Merrill CE Stamps LD Wener MH . Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol 2003; 30: 1495–1504.

8 Biesecker G Lavin L Ziskind M Koffler D . Cutaneous localization of the membrane attack complex in discoid and systemic lupus erythematosus. N Engl J Med 1982; 306: 264–270.